Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of Synflorix primary infant immunization in India with co-administered Tritanrix-HepB/Hib
2011-004644-22Phase 3
- Sponsor
- GSK
- Start
- Jun 2015
- Modality
- Vaccines & Immunotherapeutics, Device-based Delivery → Drug Delivery Systems, Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of 10-valent pneumococcal conjugate vaccine, Tritanrix HepB/Hib in pneumococcal disease, sponsored by GSK.
02
Drugs
10-valent pneumococcal conjugate vaccineTritanrix HepB/Hib
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on 2011-004644-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004644-22.